Clinical Trial Update: The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life [NA]

View source ↗

Summary

Update on a clinical trial evaluating the Apollo Device for systemic sclerosis, targeting fatigue, Raynaud phenomenon, and quality of life.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• Apollo Device

Snippet

Sponsor: Robyn T. Domsic, MD, MPH | Conditions: Systemic Sclerosis (SSc) | NA | Status: RECRUITING